Some features are required to achieve a successful response to programmed cell death protein 1 (PD-1) blockade, such as a high frequency of tumor neoantigens, the amount of infiltrating effector T cells, a high level of expression of PD-L1, or an IFN-related gene signature [8]. The gene discussed is PDCD1; the disease is neoplasm.